SURG

Value Q3, 24Q4, 24Q1, 25Q2, 25Q3, 25 TTM Total revenue 4.77 M9.6 M10.58 M11.52 M18.68 M 50.37 M Gross profit -7.83 M-11.23 M-2.94 M-2.65 M-2.6 M -19.43 M Operating expenses 6.45 M7.15 M4.64 M4.16 M4.35 M 20.29 M Selling/general/admin expenses 6.45 M7.15 M4.64 M4.16 M4.35 M 20.29 M Research & development ————— — Operating income -14.28 M-18.38 M-7.58 M-6.81 M-6.95 M -39.72 M Non-Operating Income, Total 1 018-1.71 M-55.39 K-272.3 K-539.16 K -2.57 M Interest expense, net of interest capitalized 112.81 K554.2 K119.43 K212.42 K424.67 K 1.31 M Non-Operating Income, excl. Interest Expenses -112.03 K-2.26 M-181.97 K-484.36 K-963.82 K -3.89 M Unusual income/expense 239-2397 140-3550 6 546 Pretax income -14.28 M-20.09 M-7.64 M-7.08 M-7.49 M -42.29 M Equity in earnings ————— — Taxes 0-100 K000 -100 K Non-controlling/minority interest -4 397-172.56 K-209-209-227 -173.2 K After tax other income/expense ————— — Net income before discontinued operations -14.28 M-19.81 M-7.64 M-7.08 M-7.49 M -42.02 M Discontinued operations ——0—— — Net income -14.28 M-19.81 M-7.64 M-7.08 M-7.49 M -42.02 M Dilution adjustment ————— — Preferred dividends ————— — Diluted net income available to common stockholders -14.28 M-19.81 M-7.64 M-7.08 M-7.49 M -42.02 M Basic earnings per share (Basic EPS) -0.73-1.07-0.38-0.36-0.38 -2.19 Diluted earnings per share (Diluted EPS) -0.73-1.07-0.38-0.36-0.38 -2.19 Average basic shares outstanding 19.69 M19.12 M20.07 M19.89 M19.84 M 78.92 M Diluted shares outstanding 19.69 M19.12 M20.07 M19.89 M19.84 M 78.92 M EBITDA -13.81 M-17.67 M-7.49 M-6.74 M-6.92 M -38.83 M EBIT -14.28 M-18.38 M-7.58 M-6.81 M-6.95 M -39.72 M Cost of revenue 12.6 M20.83 M13.52 M14.17 M21.28 M 69.8 M Other cost of goods sold 0———— — Depreciation & amortization (cash flow) 469.31 K709.62 K86.12 K66.36 K26.84 K 888.95 K